Michael Richard Dwyer Ashton
Chairman chez Komix Ltd.
Profil
Michael Richard Dwyer Ashton is currently the Chairman of Komix Ltd.
He previously served as the Chief Executive Officer of SkyePharma Plc, Chairman, President & Chief Executive Officer of Faulding, Inc., Chief Executive Officer & Group President of LMA International NV, Chief Executive Officer & Executive Director of Realm Therapeutics Plc, Director of Astralis Ltd., Director of Vital Living, Inc., Director of Transition Therapeutics, Inc., Independent Non-Executive Director of Avecho Biotechnology Ltd., Director of Proximagen Group Plc, Independent Non-Executive Director of Hikma Pharmaceuticals Plc, and Managing Director of Capital Safety Group Ltd.
Ashton holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from The University of Sydney.
Postes actifs de Michael Richard Dwyer Ashton
| Sociétés | Poste | Début |
|---|---|---|
Komix Ltd.
 Komix Ltd. Specialty StoresRetail Trade Komix Ltd. provides retail sale of other goods. The private company is based in Hillingdon, UK. | Chairman | - |
Anciens postes connus de Michael Richard Dwyer Ashton
| Sociétés | Poste | Fin |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Director/Board Member | 19/05/2017 |
| REALM THERAPEUTICS PLC | Chief Executive Officer | 12/06/2015 |
| AVECHO BIOTECHNOLOGY LIMITED | Director/Board Member | 24/08/2010 |
Vital Living, Inc.
 Vital Living, Inc. Pharmaceuticals: MajorHealth Technology Vital Living, Inc. manufactures and markets bionutritionals and nutraceuticals. It develops nutritional products, utilizing drug delivery technologies, including the geomatrix technology through its affiliation with SkyePharma Plc. The company was founded on January 22, 2001 and is headquartered in Boca Raton, FL. | Director/Board Member | 05/10/2006 |
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Director/Board Member | 16/07/2006 |
Formation de Michael Richard Dwyer Ashton
| Rutgers State University of New Jersey | Masters Business Admin |
| The University of Sydney | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AVECHO BIOTECHNOLOGY LIMITED | Health Technology |
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 10 |
|---|---|
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
| Faulding, Inc. | Health Technology |
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
Vital Living, Inc.
Vital Living, Inc. Pharmaceuticals: MajorHealth Technology Vital Living, Inc. manufactures and markets bionutritionals and nutraceuticals. It develops nutritional products, utilizing drug delivery technologies, including the geomatrix technology through its affiliation with SkyePharma Plc. The company was founded on January 22, 2001 and is headquartered in Boca Raton, FL. | Health Technology |
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
LMA International NV
 LMA International NV Medical SpecialtiesHealth Technology LMA International NV engages in the designing, developing, marketing and distributing of medical equipment. It operates in the Anaesthesia and Related Products, and Urology segments. The Anaesthesia and Related Products segment is managed through the subsidiary in the United States, LMA North America, and International, where business is undertaken through the remaining subsidiaries. The Urology segment owns the rights to a lithotripsy device that treats stones. The company was founded by Robert Gaines-Cooper on July 28, 1998 and is headquartered in Willemstad, Netherlands. | Health Technology |
Proximagen Group Plc
 Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
Capital Safety Group Ltd.
 Capital Safety Group Ltd. Industrial ConglomeratesProducer Manufacturing Capital Safety Group Ltd. designs and markets height safety and fall protection equipment. The firm develops and markets height safety equipment including harnesses, lanyards, anchors, horizontal systems, vertical lifelines, bloks, survival kits, flexiguards, guardrail systems, and netting solutions. The company was founded on September 8, 2005 and is headquartered in Redditch, the United Kingdom. | Producer Manufacturing |
Komix Ltd.
Komix Ltd. Specialty StoresRetail Trade Komix Ltd. provides retail sale of other goods. The private company is based in Hillingdon, UK. | Retail Trade |
